ROCKVILLE, Md., Dec. 12, 2017 /PRNewswire/ -- BioHealth Innovation, Inc. (BHI) announced that its Board of Directors has unanimously approved the appointments of three new board members, Ashish K. Kulkarni, PhD, Executive Vice President and Chief Technology Officer of Avantor, Anne S. Lindblad, PhD, President and CEO, The Emmes Corporation, and Kurt Newman, MD, President and Chief Executive Officer, Children's National Hospital.
"I am honored to welcome our new members to the board," said Richard Bendis, BHI President and CEO. "Ashish, Anne, and Kurt bring years of biohealth experience and fresh perspectives to our board."
Ashish K. Kulkarni, PhD, has been Executive Vice President and Chief Technology Officer of Avantor since 2016 with extensive experience serving in similar roles in several global corporations. During his career he has experienced and used multiple innovation models and delivered significant business impact. All the products launched under his watch in his career have multi-billion-dollar annualized sales. Avantor, a global supplier of ultra-high-purity materials for the life sciences and advanced technology industries, recently completed its acquisition of VWR Corporation, the leading global independent provider of product, supply chain, and service solutions to laboratory and production customers.
Anne Lindblad, PhD, is President and CEO of The Emmes Corporation, a 40-year-old company that conducts clinical trials and studies aimed at improving public health. She joined Emmes as a biostatistician in 1982 and was named President/CEO in 2013. In addition to her leadership role at Emmes, she serves as Principal Investigator for clinical research projects spanning diverse disease areas, authors papers for scientific journals, and is active in industry associations including the Society for Clinical Trials. Emmes, the Washington area's fifth largest bioscience employer, recently was named one of the area's top women-owned businesses by the Washington Business Journal.
Since joining Children's Health as a surgical fellow over 30 years ago, Kurt Newman, MD has risen to the position of CEO. He has fostered a culture of patient-centered care and championed innovations in research, operations, and clinical care. He has forged productive partnerships with other health systems in the region, with government and community entities and with industry at the local, national, and global level. Children's National is ranked as one of the nation's top ten children's hospitals by U.S. News & World Report.
"Ashish, Anne, and Kurt's expertise is respected globally," said Douglas Liu, SVP Global Operations, QIAGEN and Chairman BHI Board of Directors. "They will make a significant contribution to the BHI Board."
BHI also would like to thank Richard M. Ivey and David Gillece for their many years of service as they depart from its Board of Directors.
About BioHealth Innovation, Inc.
BioHealth Innovation, Inc., is a regional innovation intermediary which supports the transformation of research projects into new business opportunities in partnership with the region's rich assets, institutions, and entrepreneurial community. BHI achieves this goal by being a catalytic partner in the economic development ecosystem. Learn more at www.biohealthinnovation.org.
Phone: 301-637-6439, email: firstname.lastname@example.org
SOURCE BioHealth Innovation, Inc.